Please login to the form below

Not currently logged in
Email:
Password:

President Trump

This page shows the latest President Trump news and features for those working in and with pharma, biotech and healthcare.

Tit for tat as PBMs blame pharma for high drug prices

Tit for tat as PBMs blame pharma for high drug prices

Doing away with rebates is one of the main elements in President Trump’s plan to reduce drug prices, and the PBMs – often referred to as the ‘middlemen’ in the drug ... Yesterday, the PBMs struck back, with Humana’s president of healthcare

Latest news

  • NCI head Sharpless named as interim FDA chief NCI head Sharpless named as interim FDA chief

    A permanent successor must be nominated by President Trump and confirmed by the Senate, however, and Sharpless isn’t the only name linked to the FDA’s top job. ... the FDA,” adding: “It will be an honour to advance the FDA’s critical public

  • Trump budget targets rebates, out-of-pocket costs Trump budget targets rebates, out-of-pocket costs

    President Trump has sent a $4.75trn annual budget proposal to Congress that includes cuts to spending on Medicare and Medicaid, as well as a raft of measures aimed at reducing ... At a White House press conference Office of Management and Budget (OMB)

  • FDA chief Scott Gottlieb to step down FDA chief Scott Gottlieb to step down

    The news has nevertheless come as a surprise to the pharma and biotech sectors, where Gottlieb has been viewed as a great success since being appointed by President Trump in 2017. ... Harvard University professor and FDA expert Daniel Carpenter told the

  • Novartis back in the spotlight over Trump/Cohen links Novartis back in the spotlight over Trump/Cohen links

    President Trump’s former lawyer Michael Cohen has explained why Novartis paid him $1.2m to act as a consultant on the Trump administration, to the embarrassment of the drugmaker. ... He told the House Oversight committee members that Novartis’ $1.2m

  • Fireworks likely at Senate drug pricing hearing today Fireworks likely at Senate drug pricing hearing today

    The hearing comes against the backdrop of a recent probe into insulin pricing introduced by Grassley and his Democrat counterpart on the committee, Ron Wyden, as well as President Trump’s ... Trump’s blueprint contains some fairly unpalatable

More from news
Approximately 4 fully matching, plus 53 partially matching documents found.

Latest Intelligence

  • The Orkambi blame game The Orkambi blame game

    These included questions to Jeff Leiden about his salary, the company’s profits and taxes paid in the UK, and allegations from President Trump that European countries such as the UK

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Current global president, worldwide research and development and medical, Mikael Dolsten, will also become chief medical officer. ... This was because Read had agreed to reverse previously announced price increases after being telephoned by President

  • Change in the pharma industry is inevitable Change in the pharma industry is inevitable

    Its highly fragmented nature leaves it ripe for further M&A activity - led by emboldened and cash-rich US firms if President Trump, via a low ‘repatriation tax’, opens the door ... And then there is the problem of public opinion. “We have a

  • Focus on the fundamentals Focus on the fundamentals

    Brexit, Trump becoming president and in France a movement that did not exist two years ago holding the parliamentary majority.

  • Pharma deals continue to slide Pharma deals continue to slide

    With the dysfunctional political system in the US it is hardly surprising that eight months following President Trump’s inauguration, the repeal of Obamacare has been dropped and the pricing and ... Similarly, the Euro is now around 10% stronger

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Investing in our People
As a small, boutique agency we can and do invest heavily in our team, who produce amazing results for our clients....
Body image and mental health: The psoriasis connection
As part of mental health awareness week, the Mental Health Foundation (MHF) have released a new report on the interaction between body image and mental health. Our Medical Writer Alex...
It’s not the end of the world, is it?
Industry change isn’t always gradual – it can be apocalyptic...

Infographics